Aldeyra Therapeutics
(NASDAQ:ALDX)
$3.34
0.26[8.44%]
At close: Mar 28
$3.34
0[0.00%]
After Hours: 7:32PM EDT
Consensus Rating1
Buy
Highest Price Target1
$8.00
Lowest Price Target1
$8.00
Consensus Price Target1
$10.60

Aldeyra Therapeutics Stock (NASDAQ:ALDX), Analyst Ratings, Price Targets, Predictions

Aldeyra Therapeutics Inc has a consensus price target of $10.6, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from Citigroup, Oppenheimer, and Oppenheimer on October 17, 2023, October 17, 2023, and August 9, 2023. With an average price target of $7.33 between Citigroup, Oppenheimer, and Oppenheimer, there's an implied 119.56% upside for Aldeyra Therapeutics Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Citigroup
Oppenheimer
HC Wainwright & Co.
HC Wainwright & Co.
SVB Leerink

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Aldeyra Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
10/17/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34139.52%Citigroup
Yigal Nochomovitz
$25 → $8MaintainsBuyGet Alert
10/17/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34Oppenheimer
Justin Kim
DowngradeOutperform → PerformGet Alert
08/09/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34319.16%Oppenheimer
Justin Kim
→ $14ReiteratesOutperform → OutperformGet Alert
06/30/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34349.1%HC Wainwright & Co.
Matthew Caufield
→ $15ReiteratesBuy → BuyGet Alert
06/22/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34349.1%HC Wainwright & Co.
Matthew Caufield
→ $15ReiteratesBuy → BuyGet Alert
06/16/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34349.1%HC Wainwright & Co.
Matthew Caufield
→ $15ReiteratesBuy → BuyGet Alert
06/01/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34648.5%Citigroup
Yigal Nochomovitz
$28 → $25MaintainsBuyGet Alert
05/05/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34349.1%HC Wainwright & Co.
Matthew Caufield
→ $15Reiterates → BuyGet Alert
03/10/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34738.32%Citigroup
Yigal Nochomovitz
$23 → $28MaintainsBuyGet Alert
03/10/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34349.1%HC Wainwright & Co.
Matthew Caufield
→ $15Reiterates → BuyGet Alert
03/01/2023ALDXBuy Now
Aldeyra Therapeutics
$3.34349.1%HC Wainwright & Co.
Matthew Caufield
→ $15Reiterates → BuyGet Alert
11/21/2022ALDXBuy Now
Aldeyra Therapeutics
$3.34588.62%Citigroup
Yigal Nochomovitz
$26 → $23MaintainsBuyGet Alert
06/09/2022ALDXBuy Now
Aldeyra Therapeutics
$3.34678.44%Citigroup
Yigal Nochomovitz
$21 → $26MaintainsBuyGet Alert
04/27/2022ALDXBuy Now
Aldeyra Therapeutics
$3.34349.1%HC Wainwright & Co.
Andrew Fein
→ $15Assumes → BuyGet Alert
12/21/2021ALDXBuy Now
Aldeyra Therapeutics
$3.34528.74%Citigroup
Yigal Nochomovitz
$25 → $21MaintainsBuyGet Alert
12/21/2021ALDXBuy Now
Aldeyra Therapeutics
$3.34349.1%SVB Leerink
Marc Goodman
$24 → $15MaintainsOutperformGet Alert
04/28/2021ALDXBuy Now
Aldeyra Therapeutics
$3.34648.5%Citigroup
Yigal Nochomovitz
$22 → $25MaintainsBuyGet Alert

FAQ

Q

What is the target price for Aldeyra Therapeutics (ALDX)?

A

The latest price target for Aldeyra Therapeutics (NASDAQ: ALDX) was reported by Citigroup on October 17, 2023. The analyst firm set a price target for $8.00 expecting ALDX to rise to within 12 months (a possible 139.52% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Aldeyra Therapeutics (ALDX)?

A

The latest analyst rating for Aldeyra Therapeutics (NASDAQ: ALDX) was provided by Citigroup, and Aldeyra Therapeutics maintained their buy rating.

Q

When was the last upgrade for Aldeyra Therapeutics (ALDX)?

A

There is no last upgrade for Aldeyra Therapeutics.

Q

When was the last downgrade for Aldeyra Therapeutics (ALDX)?

A

The last downgrade for Aldeyra Therapeutics Inc happened on October 17, 2023 when Oppenheimer changed their price target from N/A to N/A for Aldeyra Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Aldeyra Therapeutics (ALDX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aldeyra Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aldeyra Therapeutics was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.

Q

Is the Analyst Rating Aldeyra Therapeutics (ALDX) correct?

A

While ratings are subjective and will change, the latest Aldeyra Therapeutics (ALDX) rating was a maintained with a price target of $25.00 to $8.00. The current price Aldeyra Therapeutics (ALDX) is trading at is $3.34, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch